Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2018 1
2020 3
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Mast Cell Regulation and Irritable Bowel Syndrome: Effects of Food Components with Potential Nutraceutical Use.
Uranga JA, Martínez V, Abalo R. Uranga JA, et al. Molecules. 2020 Sep 20;25(18):4314. doi: 10.3390/molecules25184314. Molecules. 2020. PMID: 32962285 Free PMC article. Review.
One important feature of mast cells is that their population is usually increased in animal models and biopsies from patients with irritable bowel syndrome (IBS). Therefore, mast cells and mast cell mediators are regarded as key components in IBS pathophysiol …
One important feature of mast cells is that their population is usually increased in animal models and biopsies from patients with irrita
Medical Use of Cannabinoids.
Fraguas-Sánchez AI, Torres-Suárez AI. Fraguas-Sánchez AI, et al. Drugs. 2018 Nov;78(16):1665-1703. doi: 10.1007/s40265-018-0996-1. Drugs. 2018. PMID: 30374797 Review.
As a result, it has been reported that changes in endocannabinoid levels may be related to neurological diseases such as Parkinson's disease, Huntington's disease, Alzheimer's disease and multiple sclerosis, as well as anorexia and irritable bowel syndrome. A …
As a result, it has been reported that changes in endocannabinoid levels may be related to neurological diseases such as Parkinson's disease …
Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes.
Russo EB. Russo EB. Cannabis Cannabinoid Res. 2016 Jul 1;1(1):154-165. doi: 10.1089/can.2016.0009. eCollection 2016. Cannabis Cannabinoid Res. 2016. PMID: 28861491 Free PMC article. Review.
Medicine continues to struggle in its approaches to numerous common subjective pain syndromes that lack objective signs and remain treatment resistant. Foremost among these are migraine, fibromyalgia, and irritable bowel syndrome, disorders that may overlap i …
Medicine continues to struggle in its approaches to numerous common subjective pain syndromes that lack objective signs and remain treatment …
Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
Martínez V, Iriondo De-Hond A, Borrelli F, Capasso R, Del Castillo MD, Abalo R. Martínez V, et al. Int J Mol Sci. 2020 Apr 26;21(9):3067. doi: 10.3390/ijms21093067. Int J Mol Sci. 2020. PMID: 32357565 Free PMC article. Review.
Phytocannabinoids (terpenophenolic compounds derived from the plant), include the well-known psychoactive cannabinoid delta(9)-tetrahydrocannabinol, and many non-psychoactive cannabinoids, like cannabidiol. The endocannabinoid system (ECS) comprises of endocannabinoid liga …
Phytocannabinoids (terpenophenolic compounds derived from the plant), include the well-known psychoactive cannabinoid delta(9)-tetrahydrocan …
Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases.
Maselli DB, Camilleri M. Maselli DB, et al. Clin Gastroenterol Hepatol. 2020 Jul 13:S1542-3565(20)30504-8. doi: 10.1016/j.cgh.2020.04.020. Online ahead of print. Clin Gastroenterol Hepatol. 2020. PMID: 32673642 Review.
Cannabis and cannabinoids (such as tetrahydrocannabinol and cannabidiol) are frequently used to relieve gastrointestinal symptoms. ...Cannabinoid-based therapies can also hide symptoms and disease processes, such as in patients with inflammatory bowel diseases. It i …
Cannabis and cannabinoids (such as tetrahydrocannabinol and cannabidiol) are frequently used to relieve gastrointestinal symptoms. .. …
Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?
Khalid S, Almalki FA, Hadda TB, Bader A, Abu-Izneid T, Berredjem M, Elsharkawy ER, Alqahtani AM. Khalid S, et al. Curr Pharm Des. 2021;27(13):1564-1578. doi: 10.2174/1381612826666201202125807. Curr Pharm Des. 2021. PMID: 33267756 Review.
However, the approval of some cannabinoids by the FDA (along with other recognized national medical health systems) has opened the horizon for the use of these natural drugs in medicines such as Epidiolex (cannabidiol, used for the treatment of severe forms of epilepsy) an …
However, the approval of some cannabinoids by the FDA (along with other recognized national medical health systems) has opened the horizon f …
Effects of Cannabidiol Chewing Gum on Perceived Pain and Well-Being of Irritable Bowel Syndrome Patients: A Placebo-Controlled Crossover Exploratory Intervention Study with Symptom-Driven Dosing.
van Orten-Luiten AB, de Roos NM, Majait S, Witteman BJM, Witkamp RF. van Orten-Luiten AB, et al. Cannabis Cannabinoid Res. 2021 Feb 11. doi: 10.1089/can.2020.0087. Online ahead of print. Cannabis Cannabinoid Res. 2021. PMID: 33998882
Background: Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders. ...Anecdotal reports and preclinical data suggest that the endocannabinoid system and functionally related mechanisms could offer treatment targets. Cannabidio
Background: Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders. ...Anecdotal reports a …
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease.
Izzo AA, Muccioli GG, Ruggieri MR, Schicho R. Izzo AA, et al. Handb Exp Pharmacol. 2015;231:423-47. doi: 10.1007/978-3-319-20825-1_15. Handb Exp Pharmacol. 2015. PMID: 26408170 Review.
A pharmacological modulation of the endocannabinoid system might be beneficial for widespread diseases such as gastrointestinal reflux disease, irritable bowel syndrome, inflammatory bowel disease, colon cancer, cystitis, and hyperactive bladder. Drugs …
A pharmacological modulation of the endocannabinoid system might be beneficial for widespread diseases such as gastrointestinal reflux disea …